People under 40 could be asked to take an alternative jab to AstraZeneca, members of the Joint Committee on Vaccination and Immunisation (JCVI) have said. The Government’s independent scientific advisers said a fresh risk/benefit assessment of the vaccine in different age brackets would be made before the rollout reaches those below the age of 40.
Prof Anthony Harnden, deputy chairman of the JCVI said that safety data will be examined “in scrupulous detail” before the programme is rolled out to the under 40s.
